Biocon unit’s Covid test technology may hit market soon

Biocon’s subsidiary Syngene has developed testing technology for coronavirus which it says provides better results than existing technology. The company is in discussions with test-kit manufacturers to bring the technology to market.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News
https://ift.tt/2Zgrfg1